What is the elimination half-life of amlodipine and how long does it take to be completely eliminated from the body?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amlodipine Elimination Time from the Body

Amlodipine has a long terminal elimination half-life of 30-50 hours, requiring approximately 5-7 days (5-7 half-lives) for complete elimination from the body after discontinuation. 1

Pharmacokinetic Profile of Amlodipine

Half-life and Elimination

  • Amlodipine exhibits a biphasic elimination pattern with a terminal elimination half-life of approximately 30-50 hours 1
  • Complete elimination of a drug typically takes 5-7 half-lives, meaning amlodipine requires 5-7 days (150-350 hours) to be fully cleared from the system 1, 2
  • Steady-state plasma levels are reached after 7-8 days of consecutive daily dosing, reflecting this long elimination period 1

Metabolism and Excretion

  • Amlodipine is extensively metabolized in the liver (about 90% converted to inactive metabolites) 1
  • Approximately 10% of the parent compound and 60% of metabolites are excreted in urine 1
  • The drug is highly protein-bound (93% bound to plasma proteins in hypertensive patients) 1, 3

Factors Affecting Elimination Time

Patient-Specific Factors

  • Age: Elderly patients have decreased clearance of amlodipine with a resulting increase in AUC of approximately 40-60% 1
  • Hepatic function: Patients with hepatic insufficiency have decreased clearance and longer elimination times 1
    • The plasma elimination half-life is extended to approximately 56 hours in patients with impaired hepatic function 1
  • Heart failure: Patients with moderate to severe heart failure show increased AUC similar to elderly patients 1

Renal Function

  • The pharmacokinetics of amlodipine are not significantly influenced by renal impairment 1
  • Patients with renal failure may receive the usual initial dose without adjustment for elimination concerns 1

Clinical Implications of Amlodipine's Long Half-Life

Persistent Antihypertensive Effect

  • The long elimination half-life contributes to a prolonged antihypertensive effect that extends beyond 24 hours 4
  • Research has shown that blood pressure does not significantly increase even after 3 days of medication discontinuation 4
  • This extended duration of action provides a buffer against missed doses, maintaining blood pressure control 2, 4

Adherence Testing Considerations

  • In chemical adherence testing for hypertension medications, amlodipine's slow clearance means it can be analytically positive up to a week after the last ingestion 5
  • This characteristic can make it difficult to distinguish between regular and sporadic dosing in adherence monitoring 5

Drug Interactions During Elimination Period

  • As a CYP3A substrate, strong CYP3A inhibitors may increase amlodipine plasma concentrations and potentially extend elimination time 1
  • Amlodipine itself is a weak inhibitor of CYP3A and may affect the elimination of other drugs metabolized by this pathway 1

Practical Considerations

Discontinuation Protocol

  • Due to the gradual elimination, abrupt discontinuation of amlodipine does not typically cause rebound hypertension 2
  • When switching to another antihypertensive medication, the persistent effect of amlodipine should be considered during the transition period 4

Monitoring After Discontinuation

  • Blood pressure monitoring should continue for at least 5-7 days after discontinuation to ensure proper transition to alternative therapy if needed 2, 4
  • The gradual offset of action helps prevent acute blood pressure fluctuations during medication changes 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.